Doximity, Inc. Q3 2026 Earnings Recap

Doximity reported strong Q3 2026 results with $185 million in revenue, reflecting a 10% year-over-year growth, and exceeded adjusted EBITDA expectations, signaling solid operational performance amidst increasing engagement and AI adoption.

Key Takeaways

• Revenue of $185 million surpassed guidance, marking a 10% YoY growth.
• Adjusted EBITDA margin reached 60%, significantly above expectations at $111 million.
• Surpassed 3 million registered users, capturing over 85% of US physicians on the platform.
• Over 300,000 unique prescribers actively used Doximity's AI tools, indicating robust adoption.
• The Doximity Dialer maintained its position as the top telehealth platform for the fifth consecutive year, underscoring strong competitive standing.